Collaborations in Cancer Research: Tools for Partnership and Commercialization

Collaborations, the transfer of technology, and other types of public-private partnerships, are critical to NCI’s mission of fostering the best cancer research and promoting translation of that research from the bench to the bedside. NCI is the primary means of support for cancer research in America, with 3.8 billion dollars spent in 2007 alone on

Researchers Develop a Method to Evaluate Variations Identified in Breast Cancer Susceptibility Genes

Using mouse embryonic stem cells, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have developed a new method to evaluate which mutations, or changes, in a gene known to increase breast cancer susceptibility, may lead to cancer. The new test, called a functional assay, is more comprehensive and reliable

Cooperative Groups Help Advance Cancer Research

The NCI supports an average of over 1,300 clinical trials a year in the areas of prevention, screening, diagnostics, treatment, quality of life, supportive care, and genetics. Conducting clinical trials across multiple institutions in numerous locations requires a great deal of coordination to insure quality and consistency throughout all aspects of the trial, triggering the

Tobacco Use, Secondhand Smoke Exposure during Pregnancy, May Threaten Health of Women and Children in Developing Nations

Findings from a National Institutes of Health (NIH) study indicate that rates of tobacco use during pregnancy, as well as exposure of pregnant women and their young children to secondhand smoke, are significant threats to health in several low and middle-income countries. In a few of the countries sampled, including some in Latin America, rates